Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Emerg Med ; 37(4): 369-75, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19097731

RESUMO

BACKGROUND: Cardiac arrest remains one of the leading causes of death worldwide. European Resuscitation Council Guidelines for Resuscitation 2005 recommend epinephrine for its treatment. OBJECTIVES: To estimate whether the administration of a vasodilatator such as nitroglycerin in combination with epinephrine during cardiopulmonary resuscitation would improve resuscitation outcome in an established model of ventricular fibrillation. DESIGN: Prospective, randomized, blinded, controlled study. SETTING: Animal research laboratory. Ventricular fibrillation was induced in 20 Landrace/Large-White pigs. It remained untreated for 8 min before attempting resuscitation precordial compressions, mechanical ventilation, and electrical defibrillation. Animals were randomized into two groups, 10 animals each. Group A received saline as placebo (10 mL dilution, bolus) and epinephrine (0.02 mg/kg). Group B received nitroglycerin (50 microg/kg) and epinephrine (0.02 mg/kg) during cardiopulmonary resuscitation. Electrical defibrillation was attempted after 10 min of ventricular fibrillation. RESULTS: Four animals in group A restored spontaneous circulation in comparison to eight in Group B. Coronary perfusion pressure (p < 0.0001) was significantly increased in Group B during cardiopulmonary resuscitation. CONCLUSION: A vasodilatator, when administered in combination with a vasopressor such as epinephrine during cardiopulmonary resuscitation, increases coronary perfusion pressure.


Assuntos
Epinefrina/administração & dosagem , Parada Cardíaca/tratamento farmacológico , Reperfusão Miocárdica/métodos , Nitroglicerina/administração & dosagem , Simpatomiméticos/administração & dosagem , Vasodilatadores/administração & dosagem , Fibrilação Ventricular/tratamento farmacológico , Animais , Reanimação Cardiopulmonar , Quimioterapia Combinada , Feminino , Parada Cardíaca/complicações , Injeções Intravenosas , Masculino , Sus scrofa , Fibrilação Ventricular/complicações
2.
Am J Emerg Med ; 26(5): 578-84, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18534288

RESUMO

STUDY OBJECTIVES: The aim of the present study was to assess whether a beta-adrenergic blocking agent such as atenolol, administered during cardiopulmonary resuscitation, would improve initial resuscitation success. METHODS: Ventricular fibrillation was induced in 20 Landrace/Large White piglets, which were left untreated for 8 minutes before attempted resuscitation with precordial compression, mechanical ventilation, and electrical defibrillation. Animals were randomized into 2 groups (10 animals each) to receive saline as placebo (20 mL dilution, bolus) + epinephrine (0.02 mg/kg) (group A) or atenolol (0.05 mg/kg per 20 mL dilution, bolus) + epinephrine (0.02 mg/kg) (group B) during cardiopulmonary resuscitation. Electrical defibrillation was attempted after 10 minutes of ventricular fibrillation. RESULTS: Nine animals in group B restored spontaneous circulation in comparison to only 4 in group A. Aortic systolic and diastolic pressures as well as coronary perfusion pressure were significantly increased during cardiopulmonary resuscitation in group B. Furthermore, postresuscitation heart rate of the atenolol-treated group was significantly decreased. CONCLUSIONS: A beta-adrenergic blocking agent, when administered during cardiopulmonary resuscitation, significantly improves initial resuscitation success and increases blood and coronary perfusion pressures during cardiopulmonary resuscitation.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Atenolol/uso terapêutico , Reanimação Cardiopulmonar/métodos , Epinefrina/uso terapêutico , Vasoconstritores/uso terapêutico , Fibrilação Ventricular/tratamento farmacológico , Antagonistas Adrenérgicos beta/administração & dosagem , Animais , Atenolol/administração & dosagem , Reanimação Cardiopulmonar/normas , Quimioterapia Combinada , Epinefrina/administração & dosagem , Feminino , Hemodinâmica , Masculino , Modelos Animais , Guias de Prática Clínica como Assunto , Distribuição Aleatória , Suínos , Vasoconstritores/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa